SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-016017
Filing Date
2023-05-01
Accepted
2023-05-01 07:27:54
Documents
22
Period of Report
2023-04-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eldn-20230426.htm   iXBRL 8-K 83263
2 EX-4.1 eldn-ex4_1.htm EX-4 150087
3 EX-4.2 eldn-ex4_2.htm EX-4 149241
4 EX-10.1 eldn-ex10_1.htm EX-10 768963
5 EX-10.2 eldn-ex10_2.htm EX-10 397528
6 EX-10.3 eldn-ex10_3.htm EX-10 40966
7 EX-10.4 eldn-ex10_4.htm EX-10 20728
8 EX-99.1 eldn-ex99_1.htm EX-99 19898
9 GRAPHIC img20068692_0.jpg GRAPHIC 7613
10 GRAPHIC img103607317_0.jpg GRAPHIC 116050
11 GRAPHIC img104530838_0.jpg GRAPHIC 116050
  Complete submission text file 0000950170-23-016017.txt   2253960

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eldn-20230426.xsd EX-101.SCH 2463
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eldn-20230426_lab.xml EX-101.LAB 13360
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eldn-20230426_pre.xml EX-101.PRE 9839
16 EXTRACTED XBRL INSTANCE DOCUMENT eldn-20230426_htm.xml XML 4703
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36620 | Film No.: 23870003
SIC: 2834 Pharmaceutical Preparations